| 1 |
Thankam FG, Sedighim S, Kuan R, Agrawal DK. Ischemia challenged epicardial adipose tissue stem cells-derived extracellular vesicles alter the gene expression of cardiac fibroblasts to cardiomyocyte like phenotype. Transl Res 2023;254:54-67. [PMID: 36273744 DOI: 10.1016/j.trsl.2022.10.004] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 2 |
Burtscher J, Soltany A, Visavadiya NP, Burtscher M, Millet GP, Khoramipour K, Khamoui AV. Mitochondrial stress and mitokines in aging. Aging Cell 2023;22:e13770. [PMID: 36642986 DOI: 10.1111/acel.13770] [Reference Citation Analysis]
|
| 3 |
Gil-cabrerizo P, Saludas L, Prósper F, Abizanda G, Echanove-gonzález de Anleo M, Ruiz-villalba A, Garbayo E, Blanco-prieto MJ. Development of an injectable alginate-collagen hydrogel for cardiac delivery of extracellular vesicles. International Journal of Pharmaceutics 2022;629:122356. [DOI: 10.1016/j.ijpharm.2022.122356] [Reference Citation Analysis]
|
| 4 |
Shao L, Shen Y, Ren C, Kobayashi S, Asahara T, Yang J. Inflammation in myocardial infarction: roles of mesenchymal stem cells and their secretome. Cell Death Discov 2022;8:452. [DOI: 10.1038/s41420-022-01235-7] [Reference Citation Analysis]
|
| 5 |
Matsuzaka Y, Yashiro R. Molecular Docking and Intracellular Translocation of Extracellular Vesicles for Efficient Drug Delivery. IJMS 2022;23:12971. [DOI: 10.3390/ijms232112971] [Reference Citation Analysis]
|
| 6 |
Ramasubramanian L, Du S, Gidda S, Bahatyrevich N, Hao D, Kumar P, Wang A. Bioengineering Extracellular Vesicles for the Treatment of Cardiovascular Diseases. Adv Biol (Weinh) 2022;6:e2200087. [PMID: 35778828 DOI: 10.1002/adbi.202200087] [Reference Citation Analysis]
|
| 7 |
Hu X, Ning X, Zhao Q, Zhang Z, Zhang C, Xie M, Huang W, Cai Y, Xiang Q, Ou C. Islet-1 Mesenchymal Stem Cells-Derived Exosome-Incorporated Angiogenin-1 Hydrogel for Enhanced Acute Myocardial Infarction Therapy. ACS Appl Mater Interfaces 2022. [PMID: 35920579 DOI: 10.1021/acsami.2c04686] [Reference Citation Analysis]
|
| 8 |
Bogdan Severus G, Ruxandra Florentina I, Robert Mihai E, Elena Codruța D, Sanda Maria C, Dragoș C, Silviu Cristian V. Extracellular Vesicles as Intercellular Communication Vehicles in Regenerative Medicine. Extracellular Vesicles - Role in Diseases, Pathogenesis and Therapy 2022. [DOI: 10.5772/intechopen.101530] [Reference Citation Analysis]
|
| 9 |
Suades R, Greco MF, Padró T, Badimon L. Extracellular Vesicles as Drivers of Immunoinflammation in Atherothrombosis. Cells 2022;11:1845. [DOI: 10.3390/cells11111845] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 7.0] [Reference Citation Analysis]
|
| 10 |
Manickam DS. Delivery of mitochondria via extracellular vesicles – A new horizon in drug delivery. Journal of Controlled Release 2022. [DOI: 10.1016/j.jconrel.2022.01.045] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 11 |
Saludas L, Garbayo E, Ruiz-Villalba A, Hernández S, Vader P, Prósper F, Blanco-Prieto MJ. ISOLATION METHODS OF LARGE AND SMALL EXTRACELLULAR VESICLES DERIVED FROM CARDIOVASCULAR PROGENITORS: A COMPARATIVE STUDY. Eur J Pharm Biopharm 2021:S0939-6411(21)00361-1. [PMID: 34968647 DOI: 10.1016/j.ejpb.2021.12.012] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 12 |
Claridge B, Lozano J, Poh QH, Greening DW. Development of Extracellular Vesicle Therapeutics: Challenges, Considerations, and Opportunities. Front Cell Dev Biol 2021;9:734720. [PMID: 34616741 DOI: 10.3389/fcell.2021.734720] [Cited by in Crossref: 19] [Cited by in F6Publishing: 21] [Article Influence: 9.5] [Reference Citation Analysis]
|
| 13 |
Gao Y, Wu D, Jia D, Guo Q, Wang M, Yang R, Zhang X, Chen M, Zhang D. Hypoxic Stem Cell-Derived Extracellular Vesicles for Cardiac Repair in Preclinical Animal Models of Myocardial Infarction: A Meta-Analysis. Stem Cells Dev 2021. [PMID: 34271845 DOI: 10.1089/scd.2021.0084] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 14 |
Yuan Z, Huang W. New Developments in Exosomal lncRNAs in Cardiovascular Diseases. Front Cardiovasc Med 2021;8:709169. [PMID: 34307511 DOI: 10.3389/fcvm.2021.709169] [Cited by in Crossref: 11] [Cited by in F6Publishing: 14] [Article Influence: 5.5] [Reference Citation Analysis]
|
| 15 |
Boffito M, Ciardelli G. Biomaterials Tailoring at the Nanoscale for Tissue Engineering and Advanced Therapies. Nanomaterials (Basel) 2021;11:1221. [PMID: 34066333 DOI: 10.3390/nano11051221] [Reference Citation Analysis]
|
| 16 |
Janjusevic M, Fluca AL, Ferro F, Gagno G, D'Alessandra Y, Beltrami AP, Sinagra G, Aleksova A. Traditional and Emerging Biomarkers in Asymptomatic Left Ventricular Dysfunction-Promising Non-Coding RNAs and Exosomes as Biomarkers in Early Phases of Cardiac Damage. Int J Mol Sci 2021;22:4937. [PMID: 34066533 DOI: 10.3390/ijms22094937] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
|
